Case Report Journal of Cardiovascular Medicine publishes imaging in Cardiovascular Medicine, case reports in Cardiovascular Medicine, videos in Cardiovascular Medicine case reports journal etc. This is further assessment and peer-reviewed by the editors of Cardiovascular Medicine Journal. It publishes Cardiovascular Case Reports, Clinical Images of Cardiology, Clinical Studies of Cardiac medicines, Clinical and Experimental Studies, Cardiovascular Medicine Research, Case Series, Original Research Articles. Focusing on the medicine Anticoagulants, Antiplatelet Agents, Angiotensin-Converting Enzyme (ACE), Angiotensin II Receptor Blockers, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Diuretics and Vasodilators etc.

Case Report of Cardiovascular Medicine

Case Report Journal of Cardiovascular Medicine is an Editorial Tracking Based System for quality in review process for accepting original research and review articles from across the world. Review processing is performed by the editorial board members of Case Report Journal of Cardiovascular Medicine or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole Submission, Review, Peer review, Revise, Publish process.

Anticoagulants Case Reports Journal

Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Anticoagulants are a family of medications that stop your blood from clotting too easily. They can break down existing clots or prevent clots from forming in the first place. 

These medications can help stop life-threatening conditions like strokes, heart attacks and pulmonary embolisms, all of which can happen because of blood clots. They are given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks. A blood clot is a seal created by the blood to stop bleeding from wounds. Blood thinners are medicines that prevent blood clots from forming. 

They do not break up clots that you already have. But they can stop those clots from getting bigger. It's important to treat blood clots, because clots in your blood vessels and heart can cause heart attacks, strokes, and blockages. Commonly prescribed include: Apixaban (Eliquis),   Dabigatran (Pradaxa), Edoxaban (Savaysa), Heparin (various), Rivaroxaban (Xarelto), Warfarin (Coumadin).

Antiplatelet Agents Case Reports Journal

Antiplatelet are in the Journal of Cardiovascular Medicine that prevent blood clots from forming. Read about the different types of antiplatelets, how they work, and their side effects. Over time, numerous antiplatelet agents have been developed with a multitude of indications. Antiplatelet medications divide into oral and parenteral agents, and oral agents subdivide further based on the mechanism of action. Aspirin was the first antiplatelet medication and is a cyclooxygenase inhibitor. 

Other oral antiplatelet include clopidogrel, ticagrelor, and prasugrel, cilostazol, and dipyridamole. Glycoprotein IIb/IIIa inhibitors such as tirofiban and eptifibatide are only available as parenteral agents and are used in acute phases of acute coronary syndrome. This activity reviews the indications, contraindications, action, adverse events, and other key elements of antiplatelet drugs essential to clinical practice. 

Antiplatelet drugs prevent platelets from sticking together and decrease your body’s ability to form blood clots. These medications are used to treat, and may help prevent, heart attack and stroke. Aspirin is the most commonly used antiplatelet drug. The main risk associated with antiplatelet therapy is excessive bleeding. Platelets are small cells in your blood that your body uses to form clots and stop bleeding. If you have too many platelets or your platelets stick together too much, you are more likely to form clots. This clotting can take place on the inside of your arteries and lead to heart attack or stroke.

Angiotensin-Converting Enzyme in Case Reports Journal

Angiotensin-converting enzyme, or ACE, is a central component of the renin–angiotensin system, which controls blood pressure by regulating the volume of fluids in the body. It converts the hormone angiotensin I to the active vasoconstrictor angiotensin II. 

Angiotensin-converting enzyme (ACE) inhibitors are medications that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from producing angiotensin II, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder. Angiotensin II also releases hormones that raise blood pressure. Examples of ACE inhibitors: Benazepril (Lotensin), Captopril, Enalapril (Vasotec), Fosinopril, Lisinopril (Prinivil, Zestril), Moexipril, Perindopril, Quinapril (Accupril), Ramipril (Altace), Trandolapril and etc.

Visit our publishers site https://www.cardiologycasereportsjournal.org/journal/Case-Report-Journal-of-Cardiovascular-Medicine.html and Authors may submit their manuscripts through the journal's online submission portal: https://www.cardiologycasereportsjournal.org/submit.html